Awarded

Suministro de medicamento exclusivo Ravulizumab

Name: Suministro de medicamento exclusivo Ravulizumab
Creator: Hospital Infantil Universitario Niño Jesús
Published: 2026-08-11
License: https://ted.europa.eu/en/simap/legal-notice

Original language: Spanish

Track this recordWith Adjudera Pro, get alerted before a contract here runs out.

Buyer: Hospital Infantil Universitario Niño Jesús
Winners: ALEXION PHARMA SPAIN, S.L
Contract value: €157,771
Bids received: 1
Published: 11 Aug 2026
Sector: Medical equipment and pharmaceuticals
Region: Madrid
Source: Original notice on TED (558712-2026)

More awards from this buyer

Awarded	Buyer	Winner	Contract value	Published
Suministro de medicamento exclusivo Blinatumomab 38,5 microgramos inyectable (Blincyto 38,5 mcg)	Hospital Infantil Universitario Niño Jesús	AMGEN, S.A.	€115,385	29 Oct 2026
Suministro de medicamento exclusivo Ravulizumab	Hospital Infantil Universitario Niño Jesús	ALEXION PHARMA SPAIN, S.L	€157,771	15 Sept 2026
Vosoritida 0,8 mg/ml inyectable	Hospital Infantil Universitario Niño Jesús	BIOMARIN PHARMACEUTICALS ESPAÑA, S.L	€195,578	1 Sept 2026
Elosulfasa alfa 1 mg/ml inyectable 5 ml	Hospital Infantil Universitario Niño Jesús	BIOMARIN PHARMACEUTICALS ESPAÑA, S.L	€123,362	1 Sept 2026
Cerliponasa alfa 150 mg iny perf vial	Hospital Infantil Universitario Niño Jesús	BIOMARIN PHARMACEUTICALS ESPAÑA, S.L	€457,080	1 Sept 2026
Medicamento exclusivo Setmelanotida 10 mg/ml inyectable 1 ml (envase 1 vial)	Hospital Infantil Universitario Niño Jesús	EUROMED PHARMA SPAIN S.L.	€424,819	28 Aug 2026